Style | Citing Format |
---|---|
MLA | Alibolandi M, et al.. "The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model." European Journal of Pharmaceutics and Biopharmaceutics, vol. 94, no. , 2015, pp. 521-531. |
APA | Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F (2015). The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model. European Journal of Pharmaceutics and Biopharmaceutics, 94(), 521-531. |
Chicago | Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. "The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model." European Journal of Pharmaceutics and Biopharmaceutics 94, no. (2015): 521-531. |
Harvard | Alibolandi M et al. (2015) 'The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model', European Journal of Pharmaceutics and Biopharmaceutics, 94(), pp. 521-531. |
Vancouver | Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F. The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model. European Journal of Pharmaceutics and Biopharmaceutics. 2015;94():521-531. |
BibTex | @article{ author = {Alibolandi M and Sadeghi F and Abnous K and Atyabi F and Ramezani M and Hadizadeh F}, title = {The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model}, journal = {European Journal of Pharmaceutics and Biopharmaceutics}, volume = {94}, number = {}, pages = {521-531}, year = {2015} } |
RIS | TY - JOUR AU - Alibolandi M AU - Sadeghi F AU - Abnous K AU - Atyabi F AU - Ramezani M AU - Hadizadeh F TI - The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model JO - European Journal of Pharmaceutics and Biopharmaceutics VL - 94 IS - SP - 521 EP - 531 PY - 2015 ER - |